BRIEF published on 05/01/2024 at 15:05, 1 year 7 months ago Locke Bio Partners with Flex to Expand Financial Options for Telehealth Merchants Locke Bio Flex Financial App Telehealth Funding Healthcare Financial Solutions Digital Health Platforms
PRESS RELEASE published on 05/01/2024 at 15:00, 1 year 7 months ago Locke Bio Introduces New Funding Options for Telehealth Merchants Through Flex Locke Bio partners with Flex to offer working capital solutions to telehealth merchants, bridging the gap between healthcare and e-commerce for sustainable growth Working Capital Financial Solutions Locke Bio Flex Telehealth Merchants
PRESS RELEASE published on 11/16/2023 at 15:00, 2 years ago Locke Bio Adds Two Additional Nationwide Pharmacies to Its Growing List of Fulfillment Partners
PRESS RELEASE published on 11/02/2023 at 14:00, 2 years 1 month ago Locke Bio and LegitScript's Partnership Proves To Significantly Accelerate Telehealth Certification Process
Published on 12/05/2025 at 02:35, 3 hours 38 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 13 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 8 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 13 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 42 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 22 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 47 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 58 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 2 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 13 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 28 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 28 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 12 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
